Winterer, G; Konrad, A; Vucurevic, G et al.
Association of 5' end neurregulin-1 (NRG1) gene variation with subcortical medial frontal microstructure in humanNeuroimage. Bd. 40. H. 2. 2008 S. 712-718
Fehr, C; Yakushev, I; Hohmann, N et al.
Association of low striatal dopamine D2 receptor availabilty with nicotine dependence similar to that seen with other drugs of abuseAm J Psychiatry. Bd. 165. H. 4. 2008 S. 507-514
Philipsen, A; Limberger, MF; Lieb, K et al.
Attention-Deficit Hyperactivity Disorder as a potentially aggravating factor in Borderline Personality DisorderBr J Psychiatry. Bd. 192. 2008 S. 118-123
Scheurich, A
Atypische Neuroleptika in der Schizophreniebehandlung: Verbessern sie wirklich die kognitiven Fähigkeiten?Info Neurologie & Psychiatrie. Bd. 10. H. 03. 2008 S. 19-20
Bohus, M; Lieb, K
Borderline-Persönlichkeitsstörungen (ICD-10 F6)Voderholzer, Hohagen (Hrsg). Therapie psychischer Erkrnakungen. State of the Art. 4. Aufl. München: Elsevier, Urban und Fischer 2008
Grunder, G; Fellows, C; Janouschek, H et al.
Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study.Am J Psychiatry. Bd. 165. H. 8. 2008 S. 988-95
Soyka, M; Koller, G; Schmidt, P et al.
Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependenceJ Clin Psychopharmacol. Bd. 28. H. 3. 2008 S. 317-324
Yakushev, I; Landvogt, C; Buchholz, HG et al.
Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18Psychiatry Res. Bd. 164. H. 2. 2008 S. 143-153
Böer, U; Cierny, I; Krause, D et al.
Chronic lithium salt treatment reduces CRE/CREB-directed gene transcription and reverses its upregulation by chronic psychosocial stress in transgenic reporter gene miceNeuropsychopharmacology. Bd. 33. H. 10. 2008 S. 2407-2415
Hiemke, C
Clinical utility of drug measurement and pharmacokinetics - therapeutic drug monitoring in psychiatryEur J Pharmacol. Bd. 64. H. 2. 2008 S. 159-166